Aclaris Therapeutics Sets Terms for $75 Million IPO

Published: Sep 28, 2015

Aclaris Therapeutics, which is developing a proprietary hydrogen peroxide solution for common skin lesions, announced terms for its IPO on Friday.

The Malvern, PA-based company plans to raise $75 million by offering 5.0 million shares at a price range of $14 to $16. At the midpoint of the proposed range, Aclaris Therapeutics would command a fully diluted market value of $301 million.

Help employers find you! Check out all the jobs and post your resume.

Back to news